Lanarkshire-based biotechnology company ILC Therapeutics has completed a £3.5m pre-IPO funding round.
Investors include Los Angeles-based lawyer and investor Robert Kopple; St Andrews-based Eos Angel Investment Syndicate; Scottish Enterprise; and members of ILCT’s management.
Read more HERE.




